As of 2025-07-05, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (79.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.08 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -415.3%.
The range of the Relative Valuation is (79.51) - (100.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 18.0x | 13.3x |
| Forward P/E multiples | 14.2x - 25.0x | 14.9x |
| Fair Price | (79.51) - (100.82) | (79.06) |
| Upside | -417.0% - -502.0% | -415.3% |
| Date | P/E |
| 2025-07-03 | -4.47 |